http://www.onemedplace.com/blog/wp-content/uploads/2009/04/heart_monitor.jpg
Bioheart, a developer of cell-based therapies for cardiovascular diseases, has been granted FDA approval to proceed with a Phase I clinical trial for a potential congestive heart failure treatment.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/04/heart_monitor.jpg
A roundup of news from the Heart Failure Society of America's annual meeting.
View Article
More Pages to Explore .....
